Brief: BioVaxys Begins Toxicity Study Ahead of CoviDTH IND Submission
28/09/2021 13:28
Sept 28 (Reuters) - Biovaxys Technology Corp BIOV.CD :
* BIOVAXYS BEGINS TOXICITY STUDY AHEAD OF COVIDTH IND
SUBMISSION
Source text for Eikon: ID:nCNWVMlLwa
Further company coverage: BIOV.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biovaxys Technology
See all newsBrief: Biovaxys Appoints Former Sanofi Vaccines Executive To Board Of Directors
Brief: Biovaxys Announces Life Offering
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys Announces Consolidation And Concurrent Brokered Private Placement Offering For Gross Proceeds Of Up To $3,000,000